Sound Pharmaceuticals Stock

soundpharmaceuticals.comHealthcare / BioTech & PharmaFounded: 2001Funding to Date: $25.95MM

Sound Pharmaceuticals is a bio-pharmaceutical platform developing novel treatments to prevent and treat hearing loss and tinnitus. The company uses molecular biology, immunohistochemistry and electrophysiology that have lead to the development of preclinical models of hearing loss and tinnitus that are translating into successful clinical trials.

Register for Details

For more details on financing and valuation for Sound Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Sound Pharmaceuticals.

Register Today

Sound Pharmaceuticals investors also invested in these private companies

Cystic Fibrosis Foundation

Team

Management Team

John Sullivan
Chief Financial Officer
Jonathan Kil
Chief Executive Officer & Chief Medical Officer

Other companies like Sound Pharmaceuticals in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B